Literature DB >> 23242185

Extracellular guanosine regulates extracellular adenosine levels.

Edwin K Jackson1, Dongmei Cheng, Travis C Jackson, Jonathan D Verrier, Delbert G Gillespie.   

Abstract

The aim of this investigation was to test the hypothesis that extracellular guanosine regulates extracellular adenosine levels. Rat preglomerular vascular smooth muscle cells were incubated with adenosine, guanosine, or both. Guanosine (30 μmol/l) per se had little effect on extracellular adenosine levels. Extracellular adenosine levels 1 h after addition of adenosine (3 μmol/l) were 0.125 ± 0.020 μmol/l, indicating rapid disposition of extracellular adenosine. Extracellular adenosine levels 1 h after addition of adenosine (3 μmol/l) plus guanosine (30 μmol/l) were 1.173 ± 0.061 μmol/l, indicating slow disposition of extracellular adenosine. Cell injury increased extracellular levels of endogenous adenosine and guanosine, and the effects of cell injury on endogenous extracellular adenosine were modulated by altering the levels of endogenous extracellular guanosine with exogenous purine nucleoside phosphorylase (converts guanosine to guanine) or 8-aminoguanosine (inhibits purine nucleoside phosphorylase). Extracellular guanosine also slowed the disposition of extracellular adenosine in rat preglomerular vascular endothelial cells, mesangial cells, cardiac fibroblasts, and kidney epithelial cells and in human aortic and coronary artery vascular smooth muscle cells and coronary artery endothelial cells. The effects of guanosine on adenosine levels were not mimicked or attenuated by 5-iodotubericidin (adenosine kinase inhibitor), erythro-9-(2-hydroxy-3-nonyl)-adenine (adenosine deaminase inhibitor), 5-aminoimidazole-4-carboxamide (guanine deaminase inhibitor), aristeromycin (S-adenosylhomocysteine hydrolase inhibitor), low sodium (inhibits concentrative nucleoside transporters), S-(4-nitrobenzyl)-6-thioinosine [inhibits equilibrative nucleoside transporter (ENT) type 1], zidovudine (inhibits ENT type 2), or acadesine (known modulator of adenosine levels). Guanosine also increases extracellular inosine, uridine, thymidine, and cytidine, yet decreases extracellular uric acid. In conclusion, extracellular guanosine regulates extracellular adenosine levels.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23242185      PMCID: PMC3602643          DOI: 10.1152/ajpcell.00212.2012

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  100 in total

Review 1.  Effects of homocysteine on vascular and tissue adenosine: a stake in homocysteine pathogenicity?

Authors:  Andreas Deussen; Annette Pexa; Robert Loncar; Sebastian N Stehr
Journal:  Clin Chem Lab Med       Date:  2005       Impact factor: 3.694

Review 2.  Nucleotide metabolism and cell-cell interactions.

Authors:  Holger K Eltzschig; Thomas Weissmüller; Alice Mager; Tobias Eckle
Journal:  Methods Mol Biol       Date:  2006

3.  Cyclooxygenase inhibition reveals synergistic action of vasoconstrictors on mesangial cell growth.

Authors:  T Inoue; Z Mi; D G Gillespie; E K Jackson
Journal:  Eur J Pharmacol       Date:  1998-11-20       Impact factor: 4.432

Review 4.  Hormonal and cytokine effects of uric acid.

Authors:  Laura G Sánchez-Lozada; Takahiko Nakagawa; Duk-Hee Kang; Dan I Feig; Martha Franco; Richard J Johnson; Jaime Herrera-Acosta
Journal:  Curr Opin Nephrol Hypertens       Date:  2006-01       Impact factor: 2.894

5.  Extracellular inosine modulates ERK 1/2 and p38 phosphorylation in cultured Sertoli cells: possible participation in TNF-alpha modulation of ERK 1/2.

Authors:  Luiz F Souza; Ana P Horn; Daniel P Gelain; Fernanda R Jardim; Guido Lenz; Elena A Bernard
Journal:  Life Sci       Date:  2005-06-23       Impact factor: 5.037

6.  Inosine released after hypoxia activates hepatic glucose liberation through A3 adenosine receptors.

Authors:  Raquel Guinzberg; Daniel Cortés; Antonio Díaz-Cruz; Héctor Riveros-Rosas; Rafael Villalobos-Molina; Enrique Piña
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-12-13       Impact factor: 4.310

Review 7.  Adenosine signaling in asthma and chronic obstructive pulmonary disease.

Authors:  Amir Mohsenin; Michael R Blackburn
Journal:  Curr Opin Pulm Med       Date:  2006-01       Impact factor: 3.155

8.  Identification and characterization of a novel monoamine transporter in the human brain.

Authors:  Karen Engel; Mingyan Zhou; Joanne Wang
Journal:  J Biol Chem       Date:  2004-09-23       Impact factor: 5.157

Review 9.  Role of adenosine in regulation of carbohydrate metabolism in contracting muscle.

Authors:  P Hespel; E A Richter
Journal:  Adv Exp Med Biol       Date:  1998       Impact factor: 2.622

10.  HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia.

Authors:  Holger K Eltzschig; Parween Abdulla; Edgar Hoffman; Kathryn E Hamilton; Dionne Daniels; Caroline Schönfeld; Michaela Löffler; German Reyes; Michael Duszenko; Jorn Karhausen; Andreas Robinson; Karen A Westerman; Imogen R Coe; Sean P Colgan
Journal:  J Exp Med       Date:  2005-12-05       Impact factor: 14.307

View more
  18 in total

1.  Guanosine Promotes Proliferation in Neural Stem Cells from Hippocampus and Neurogenesis in Adult Mice.

Authors:  Tetsade C B Piermartiri; Beatriz Dos Santos; Fernanda G Q Barros-Aragão; Rui D Prediger; Carla Inês Tasca
Journal:  Mol Neurobiol       Date:  2020-06-26       Impact factor: 5.590

2.  Guanosine inhibits LPS-induced pro-inflammatory response and oxidative stress in hippocampal astrocytes through the heme oxygenase-1 pathway.

Authors:  Bruna Bellaver; Débora Guerini Souza; Larissa Daniele Bobermin; Carlos-Alberto Gonçalves; Diogo Onofre Souza; André Quincozes-Santos
Journal:  Purinergic Signal       Date:  2015-10-02       Impact factor: 3.765

3.  Guanosine promotes cytotoxicity via adenosine receptors and induces apoptosis in temozolomide-treated A172 glioma cells.

Authors:  Karen A Oliveira; Tharine A Dal-Cim; Flávia G Lopes; Cláudia B Nedel; Carla Inês Tasca
Journal:  Purinergic Signal       Date:  2017-05-23       Impact factor: 3.765

4.  Intranasal guanosine administration presents a wide therapeutic time window to reduce brain damage induced by permanent ischemia in rats.

Authors:  Denise Barbosa Ramos; Gabriel Cardozo Muller; Guilherme Botter Maio Rocha; Gustavo Hirata Dellavia; Roberto Farina Almeida; Leticia Ferreira Pettenuzzo; Samanta Oliveira Loureiro; Gisele Hansel; Ângelo Cássio Magalhães Horn; Diogo Onofre Souza; Marcelo Ganzella
Journal:  Purinergic Signal       Date:  2015-12-23       Impact factor: 3.765

5.  2',3'-cGMP exists in vivo and comprises a 2',3'-cGMP-guanosine pathway.

Authors:  Edwin K Jackson; Zaichuan Mi; Keri Janesko-Feldman; Travis C Jackson; Patrick M Kochanek
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-02-21       Impact factor: 3.619

6.  Guanosine Anxiolytic-Like Effect Involves Adenosinergic and Glutamatergic Neurotransmitter Systems.

Authors:  Roberto Farina Almeida; Daniel Diniz Comasseto; Denise Barbosa Ramos; Gisele Hansel; Eduardo R Zimmer; Samanta Oliveira Loureiro; Marcelo Ganzella; Diogo Onofre Souza
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

7.  Guanosine prevents nitroxidative stress and recovers mitochondrial membrane potential disruption in hippocampal slices subjected to oxygen/glucose deprivation.

Authors:  Daniel T Thomaz; Tharine A Dal-Cim; Wagner C Martins; Maurício Peña Cunha; Débora Lanznaster; Andreza F de Bem; Carla I Tasca
Journal:  Purinergic Signal       Date:  2016-09-09       Impact factor: 3.765

8.  The guanosine-adenosine interaction exists in vivo.

Authors:  Edwin K Jackson; Zaichuan Mi
Journal:  J Pharmacol Exp Ther       Date:  2014-07-07       Impact factor: 4.030

Review 9.  Guanosine and its role in neuropathologies.

Authors:  Luis E B Bettio; Joana Gil-Mohapel; Ana Lúcia S Rodrigues
Journal:  Purinergic Signal       Date:  2016-03-22       Impact factor: 3.765

10.  Regulation of Cell Proliferation by the Guanosine-Adenosine Mechanism: Role of Adenosine Receptors.

Authors:  Edwin K Jackson; Delbert G Gillespie
Journal:  Physiol Rep       Date:  2013-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.